Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $75.6M
Liabilities Breakdown FY2010
Total Liabilities: $72.1M
Asset Breakdown
Total Assets: $75.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.3M | 4.4% |
| Accounts Receivable | $993.0K | 1.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $559.0K | 0.7% |
| Goodwill | $700.0K | 0.9% |
| Intangible Assets | $12.3M | 16.2% |
| Other Assets | $57.7M | 76.4% |
Liabilities Breakdown
Total Liabilities: $72.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.6M | 11.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $63.5M | 88.1% |